FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Articles|April 28, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 28, 2021
Author(s)Sydney Jennings
Data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 43% of total US population have received at least 1 dose
• 29.5% of total US population are fully vaccinated
• 29.5% of total US population are fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Maine: 38%
2. Connecticut: 37.2%
3. Vermont: 36.3%
4. New Mexico: 36%
5. Rhode Island: 35.4%
2. Connecticut: 37.2%
3. Vermont: 36.3%
4. New Mexico: 36%
5. Rhode Island: 35.4%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 32 210 302 confirmed cases
• 574 018 deaths
• 574 018 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 737 213
2. Texas: 2 883 059
3. Florida: 2 222 546
4. New York: 2 040 448
5. Illinois: 1 328 344
2. Texas: 2 883 059
3. Florida: 2 222 546
4. New York: 2 040 448
5. Illinois: 1 328 344
Deaths: California has the most deaths due to COVID-19 with 61 565 reported fatalities, followed by New York with 52 140, and Texas with 50 037.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 149 030 711 confirmed cases, 3 140 982 deaths, and 86 481 052 recoveries.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
FDA approves olanzapine, a once-monthly subcutaneous injection for adults with schizophrenia, boosting symptom control while reducing monitoring needs and highlighting weight risks.
The CardioGuide HF app from Abbott will show patients their pulmonary artery pressure trends and deliver medication instructions set by their care teams.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Once-Monthly Olanzapine Injection for Adults With Schizophrenia
2
Real-World Nonhormonal Therapy Effects on VMS Bother, Work, and Mood
3
Why Real-World Evidence Matters for Nonhormonal Menopause VMS Therapy
4
Abbott Gains FDA Approval for CardioMEMS Update Letting Heart Failure Patients View Pressure Readings on Their Phones
5